164 related articles for article (PubMed ID: 38144417)
1.
Wang Y; Tian Z; Huang S; Dang N
Drug Des Devel Ther; 2023; 17():3767-3781. PubMed ID: 38144417
[TBL] [Abstract][Full Text] [Related]
2. Role of keratinocytes and immune cells in the anti-inflammatory effects of Tripterygium wilfordii Hook. f. in a murine model of psoriasis.
Ru Y; Li H; Zhang R; Luo Y; Song J; Kuai L; Xing M; Hong S; Sun X; Ding X; Lu Y; Liu L; Na C; Zhou Y; Li B; Li X
Phytomedicine; 2020 Oct; 77():153299. PubMed ID: 32823074
[TBL] [Abstract][Full Text] [Related]
3. Plasma miR-126 expression correlates with risk and severity of psoriasis and its high level at baseline predicts worse response to Tripterygium wilfordii Hook F in combination with acitretin.
Duan Y; Zou J; Mao J; Guo D; Wu M; Xu N; Zhou J; Zhang Y; Guo W; Jin W
Biomed Pharmacother; 2019 Jul; 115():108761. PubMed ID: 31100542
[TBL] [Abstract][Full Text] [Related]
4. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.
Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY
J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Tripterygium wilfordii hook F versus acitretin in moderate to severe psoriasis vulgaris: a randomized clinical trial.
Wu C; Jin HZ; Shu D; Li F; He CX; Qiao J; Yu XL; Zhang Y; He YB; Liu TJ
Chin Med J (Engl); 2015 Feb; 128(4):443-9. PubMed ID: 25673443
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice.
Luo D; Zuo Z; Zhao H; Tan Y; Xiao C
Front Med; 2019 Oct; 13(5):556-563. PubMed ID: 30604167
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.
Liu L; Zhao H; Sun X; Zheng Q; Luo Y; Ru Y; Zhang Y; Chen X; Zhu B; Yin C; Li B; Li X
BMC Complement Altern Med; 2018 Aug; 18(1):243. PubMed ID: 30170584
[TBL] [Abstract][Full Text] [Related]
8. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center.
Yang L; Wang Q; Hou Y; Zhao J; Li M; Xu D; Zeng X
Clin Rheumatol; 2020 Mar; 39(3):813-821. PubMed ID: 31713733
[TBL] [Abstract][Full Text] [Related]
9. A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety.
Bao J; Dai SM
Rheumatol Int; 2011 Sep; 31(9):1123-9. PubMed ID: 21365177
[TBL] [Abstract][Full Text] [Related]
10. The Pharmacological Effects and Mechanism of Tripterygium wilfordii Hook F in Central Nervous System Autoimmunity.
Wang Q; Meng J; Dong A; Yu JZ; Zhang GX; Ma CG
J Altern Complement Med; 2016 Jul; 22(7):496-502. PubMed ID: 27224044
[TBL] [Abstract][Full Text] [Related]
11. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
12. Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-kappaB activities.
Sylvester J; Liacini A; Li WQ; Dehnade F; Zafarullah M
Mol Pharmacol; 2001 May; 59(5):1196-205. PubMed ID: 11306704
[TBL] [Abstract][Full Text] [Related]
13. [Progress of effect and mechanisms of Tripterygium wilfordii on immune system].
Nong C; Wang XZ; Jiang ZZ; Zhang LY
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3374-3383. PubMed ID: 31602898
[TBL] [Abstract][Full Text] [Related]
14. Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders.
Liu X; Lin L; Lv T; Lu L; Li X; Han Y; Qiu Z; Li X; Li Y; Song X; Cao W; Li T
Phytomedicine; 2022 Jul; 101():154103. PubMed ID: 35468451
[TBL] [Abstract][Full Text] [Related]
15. Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment.
Zhang Y; Mao X; Li W; Chen W; Wang X; Ma Z; Lin N
Med Res Rev; 2021 May; 41(3):1337-1374. PubMed ID: 33296090
[TBL] [Abstract][Full Text] [Related]
16. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.
Luo Y; Hou X; Xi A; Luo M; Wang K; Xu Z
J Ethnopharmacol; 2023 May; 307():116211. PubMed ID: 36706936
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
Goldbach-Mansky R; Wilson M; Fleischmann R; Olsen N; Silverfield J; Kempf P; Kivitz A; Sherrer Y; Pucino F; Csako G; Costello R; Pham TH; Snyder C; van der Heijde D; Tao X; Wesley R; Lipsky PE
Ann Intern Med; 2009 Aug; 151(4):229-40, W49-51. PubMed ID: 19687490
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bullous pemphigoid in Chinese patients with Tripterygium wilfordii Hook F.
Ge XL; Li SZ; Jin X; Jin HZ; Zuo YG
Dermatol Ther; 2020 Jul; 33(4):e13721. PubMed ID: 32500934
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8).
Tang W; Zuo JP
Acta Pharmacol Sin; 2012 Sep; 33(9):1112-8. PubMed ID: 22922344
[TBL] [Abstract][Full Text] [Related]
20. A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis.
Wan L; Liu J; Huang C; Wang K; Zhu Z; Li F
J Pharm Pharmacol; 2023 Nov; 75(11):1442-1457. PubMed ID: 37738207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
